Navigation Links
Dehaier Medical Announces March Investor Presentations
Date:3/1/2011

BEIJING, March 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that management will present at the following investment community conferences in March:

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

  • Rodman & Renshaw Annual China Investment Conference in Shanghai, China on March 8, 2011 at 2:25 p.m. Beijing time.
  • ROTH 23rd Annual OC Growth Stock Conference in Laguna Niguel, Calif. on March 15, 2011 at 2:00 p.m. Pacific Standard Time.

  • Investors attending the Rodman & Renshaw or ROTH conference are invited to visit management's formal presentations at the above times and venues. Attending investors are also encouraged to schedule one-on-one meeting with management at these conferences by contacting their sales person at the appropriate conference, or by contacting Lee Roth at (212) 481-2050 or dehaier@tpg-ir.com.

    About Dehaier Medical Systems Ltd.Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA) and HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier's technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.

    Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact UsIn the US:The Piacente Group, Inc. Investor Relations Brandi Floberg or Lee Roth(212) 481-2050dehaier@tpg-ir.comIn China:The Piacente Group, Inc. Investor RelationsWendy Sun+86 10-6590-7991dehaier@tpg-ir.comDehaier Medical Systems LimitedRita LiuCFO+86 10-8844-5026liuz@dehaier.com.cnAnan LiuInvestor Relations Manager+86 10-5166-0080 ext 169liuanan@dehaier.com.cn
    '/>"/>

    SOURCE Dehaier Medical Systems Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
    2. Dehaier Medical Systems Announces First Quarter Net Income Up 54%
    3. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
    4. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell
    5. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
    6. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
    7. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
    8. Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations
    9. Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair
    10. Dehaier Medical Wins $2 Million Distribution Bid for Rural Healthcare Construction Project
    11. Dehaier Medical to Participate in MEDICA International Trade Fair
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
    (Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
    (Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
    Breaking Medicine Technology:
    (Date:4/26/2017)... ... April 26, 2017 , ... Miami native and local periodontist Dr. John ... have never imagined back in 1991 that this journey would have taken me into ... last 25 years, Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally ...
    (Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® XT55 ... high-protein beverages by helping beverage manufacturers more effectively manage protein costs. “Soy protein ... savings as well as more stable pricing over time. Now it’s even more ...
    (Date:4/25/2017)... ... April 25, 2017 , ... ... topical cream that’s the first in a new class of photodynamic cosmetics (PDC). ... appearance of skin, visibly reduce outward signs of aging, and minimize the appearance ...
    (Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
    (Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... Liberty attempts to compare student test score performance for the 2015-16 school year ... the state’s voucher programs. Though it highlights important patterns in student test score ...
    Breaking Medicine News(10 mins):